Intracerebroventricular administration of APP96-110 was shown to not only restore motor and cognitive deficits, but also preserve cortical and hippocampal tissue in APP-/- mice, and reduce axonal injury in the corpus callosum following diffuse TBI in rats. The gene discussed is APP; the disease is Cognitive impairment.